Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
GLP-1-GIP co-agonist tirzepatide was approved by the US Food and Drug Administration in 2022 for the treatment of T2DM (Nogueiras et al., 2023)
It seems like we can't escape GLP-1 drugs in 2026, and I'm no exception
A prime example of these new skincare ingredient trends is the use of microscopic spicules from marine sponges, which create tiny, invisible channels to allow deeper penetration of active ingredients without tearing the surface of your face, echoing the rise of bioidentical aesthetics that stimulate natural repair instead of relying on heavy fillers
Research suggests that Epithalon may promote telomere extension, support circadian rhythm regulation, and improve oxidative stress resistance
US$ 26.78
US$ 21.83
US$ 26.60
